Founded in 1996, PSC Biotech Corporation is a global organization that has spent over two decades providing life science services and solutions through our professional service consultancy for CQV, CSV, auditing, IT services, and much more. PSC Software provides inspection/audit management and eQMS services and BioTechnique provides CRDMO services. We also distribute equipment (Lives International data loggers and thermal mapping systems). Since its inception, PSC has served as a strategic partner to emerging and established life science companies, helping them bring their life-saving products to market. | PSC Biotech® is a global specialty life sciences consultancy firms, supporting over 1000 clients in more than 35 countries. PSC Biotech Corporation® provides life science services and solutions through our professional service consultancy (CQV, CSA/CSV, Audit, and much more.) PSC Software® provides inspection management and electronic quality management systems that enable businesses to stay compliant while effectively and efficiently delivering products to market. PSC Software® has 4 proprietary, 21 CFR Part 11 compliant, cloud-based systems that accelerate and streamline quality processes. BioTechnique® is a division of PSC Biotech Corporation®. BioTechnique® is a Contract Research, Development, and Manufacturing Organization (CRDMO) that provides lyophilization and therapeutic sterile injectable fill-finish solutions to cater to both large and small investigational/clinical stage or commercial batch sizes. BioTechnique® provides a comprehensive platform for success, beginning with Formulation Studies, extending through Analytical and Formulation Development, and culminating in Product Launch (clinical or commercial). | . | BioTechnique is a CRDMO, pharmaceutical manufacturing facility located in York, PA. A highly potent sterile injectable and clinical oncolytics manufacturing company dedicated to providing cytotoxic and high potency sterile injectable fill-finish services. Our project management and client services staff work closely with clients to meet all their manufacturing needs. We provide formulation and compounding, fill-finish, lyophilization, shipping, storage, and 3rd party logistics for a wide variety of liquid injectables. BioTechnique utilizes our expertise to create process designs for client product needs. To learn more, visit www.biotechnique.com
Polish Investment & Trade Agency
The Polish Investment and Trade Agency is a mission driven, government entity, that is dedicated to promoting and growing the economy of Poland on a global stage. Anchored in Warsaw, with a network of nearly 60 foreign trade offices around the world, the Agency’s mission is to increase the awareness of Polish brands in international markets and to promote national products and services. This mission is accomplished by three pillars: promoting Polish exports, supporting the inflow of foreign direct investments to Poland and the implementation of Polish investments in the country, and the cultivation of partnerships with domestic and international stakeholders. | . | The Polish Investment and Trade Agency (PAIH) is Poland’s leading government agency dedicated to promoting Polish business on the international stage and attracting foreign investment to Poland. As a key partner for international companies looking to explore opportunities in Poland, PAIH provides comprehensive support to exporters and investors, bridging connections between global markets and the dynamic Polish economy. At the BIO International Convention, PAIH proudly coordinates the Polish National Pavilion, a platform showcasing Poland’s innovation potential in the life sciences sector. In collaboration with BioForum Central European Life Science Cluster, this year’s booth features 26 outstanding Polish companies representing the strength, diversity, and international ambitions of Poland’s biotech ecosystem. At this year’s BIO International Convention, Polish exhibitors will present cutting-edge solutions across four key categories: Drug Development, Diagnostics, Manufacturing, and Digital Solutions and Services. We invite all BIO International Convention participants to visit the Polish National Booth, meet our innovative companies, and explore partnership opportunities across the biotech value chain—from early-stage research and diagnostics to digital transformation and advanced manufacturing. | xxxx
Orbis Clinical Life Sciences Solutions
Orbis Clinical is a leading global recruiting partner to the life sciences industry; we have been driving the success of our clients, consultants, and employees in staffing and consulting services since 2004. We provide multiple solutions spanning permanent and temporary placement to clients ranging from venture-backed start-ups through Fortune 500 firms. Our mission is to provide the world’s leading life science companies with expertise essential to treating devastating diseases.
Nevada Pavilion
Southern Nevada has all the components to sustain and grow a biotech ecosystem but is looking for a few big brand companies that would help the region attract the right workforce pipeline and supply chain vendors. Southern Nevada has a strong backbone of biotech research through the region’s higher education institutions, including UNLV, a R1 research university, but also Touro University and Roseman University of Health Sciences. Recently named the best city in America for pre-IPO startups, the region also has a burgeoning tech scene, perfect for a biotech startup. Between 2018-2023, six organizations in Southern Nevada received 101 research grants from the National Institutes of Health, totaling $67 million. In Southern Nevada, you’re just a short plane ride or drive away from established biotech hubs San Diego and San Francisco. UNLV is a R1 research institution, with Roseman University offering 64k square feet of state-of-the-art research labs, including 50k square feet of wet lab space.
Murrieta Innovation Center
The Murrieta Innovation Center (MIC) is a purpose-built initiative focused on accelerating life science and health tech startups in Southwest Riverside County. With affordable wet lab infrastructure, phased program development, and strong public-private partnerships, MIC is positioned to address early-stage gaps in the regional innovation ecosystem. This plan outlines the Center’s mission, impact strategy, financial model, programming, and its call to action for funders and collaborators. **Mission:** Support life science and health tech companies from research to viability, marketability, or proof of concept. Their success is our success. **Vision:** Establish Murrieta as a launchpad for Southern California’s most promising innovation in life sciences—affordable, resource-rich, and founder-focused.
Montgomery County Economic Development Corporation
The Montgomery County Economic Development Corporation serves as the official economic development entity for Montgomery County, Maryland to accelerate business development, attraction, retention and expansion in key industry sectors while advancing equitable and inclusive economic growth. We operate as a 501(c)(3) nonprofit public-private partnership, funded by Montgomery County. | The Montgomery County Economic Development Corporation serves as the official economic development entity for Montgomery County, Maryland to accelerate business development, attraction, retention and expansion in key industry sectors while advancing equitable and inclusive economic growth.
Minnesota Pavilion
Minnesota businesses have a legacy of building things that last while changing the global economy for the better. The state boasts an extraordinary concentration of Fortune 500 companies, a fast-growing startup ecosystem that pulls in venture capital from investors worldwide, and renowned research institutions that foster innovation.
Mexico Pavilion (MEX BIO)
MEX BIO Pavilion – BIO International Convention 2026 The MEX BIO Pavilion represents Mexico’s coordinated national presence at the BIO International Convention, the world’s leading global event for biotechnology and life sciences. Since 2022, Mexico has maintained a continuous and growing participation at BIO through a national pavilion, reflecting the strategic importance of the life sciences sector for the country and the sustained collaboration between industry, government, academia, and innovation stakeholders. MEX BIO serves as a platform for international engagement, business development, and ecosystem positioning, bringing together Mexican pharmaceutical and biotechnology companies, CROs and CDMOs, startups, research institutions, clusters, and public agencies. Over the past four editions, more than 50 Mexican organizations have participated, positioning Mexico as a key life sciences hub in Latin America and a reliable partner for global collaboration. The Pavilion is designed to go beyond a traditional exhibition space. Through a curated program of activities—including MEX BIO Day, MEX BIO Talks, MEX BIO Walks, and high-level institutional engagements—the Pavilion facilitates targeted meetings, strategic dialogues, and direct interaction with international partners, investors, and decision-makers. A dedicated digital platform and ecosystem wall further enhance visibility and extend engagement before, during, and after the Convention. Mexico’s presence at BIO reflects the country’s commitment to innovation, advanced manufacturing, regulatory dialogue, and international cooperation in life sciences. The MEX BIO Pavilion offers global stakeholders a unique entry point to explore Mexico’s capabilities, connect with its innovation ecosystem, and identify opportunities for collaboration, investment, and market access in one of the region’s most dynamic life sciences environments.
LSK Global PS
LSK Global PS delivers a comprehensive, end-to-end clinical development model built on 26 years of industry experience, aligning strategy, operations, data, and regulatory functions to minimize delays, reduce risk, and ensure quality. Unified workflows across clinical operations, data management, and biostatistics enable efficient execution and timely submissions, while pharmacovigilance and medical writing are seamlessly incorporated to support submission-ready deliverables. Combined with academic and epidemiological expertise and extensive domestic and global trial experience, this approach strengthens regulatory readiness and supports successful clinical development in Korea.